Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 24092441)

1.

The PFP/RAG2 double-knockout mouse in metastasis research: small-cell lung cancer and prostate cancer.

Müller I, Ullrich S.

Methods Mol Biol. 2014;1070:191-201. doi: 10.1007/978-1-4614-8244-4_14.

PMID:
24092441
2.

Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice.

Sodeur S, Ullrich S, Gustke H, Zangemeister-Wittke U, Schumacher U.

Cancer Lett. 2009 Sep 18;282(2):146-51. doi: 10.1016/j.canlet.2009.03.005. Epub 2009 Apr 5.

PMID:
19349111
3.

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

Nanni P, Nicoletti G, Landuzzi L, Croci S, Murgo A, Palladini A, Antognoli A, Ianzano ML, Stivani V, Grosso V, Maira SM, García-Echeverría C, Scotlandi K, De Giovanni C, Lollini PL.

Eur J Cancer. 2010 Feb;46(3):659-68. doi: 10.1016/j.ejca.2009.11.018. Epub 2009 Dec 22.

PMID:
20031388
5.

Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

Lange T, Ullrich S, Müller I, Nentwich MF, Stübke K, Feldhaus S, Knies C, Hellwinkel OJ, Vessella RL, Abramjuk C, Anders M, Schröder-Schwarz J, Schlomm T, Huland H, Sauter G, Schumacher U.

Clin Cancer Res. 2012 Mar 1;18(5):1364-73. doi: 10.1158/1078-0432.CCR-11-2900. Epub 2012 Jan 18.

6.

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.

Nanni P, Nicoletti G, Palladini A, Croci S, Murgo A, Ianzano ML, Grosso V, Stivani V, Antognoli A, Lamolinara A, Landuzzi L, di Tomaso E, Iezzi M, De Giovanni C, Lollini PL.

PLoS One. 2012;7(6):e39626. doi: 10.1371/journal.pone.0039626. Epub 2012 Jun 21.

7.

An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse.

Le Dévédec SE, van Roosmalen W, Maria N, Grimbergen M, Pont C, Lalai R, van de Water B.

Clin Exp Metastasis. 2009;26(7):673-84. doi: 10.1007/s10585-009-9267-6. Epub 2009 May 24.

8.

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML.

Cancer Res. 1999 Apr 15;59(8):1987-93.

9.

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.

Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Penas EM, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Effenberger KE, Bockhorn M, Izbicki JR, Yekebas EF.

BMC Cancer. 2010 Jun 16;10:295. doi: 10.1186/1471-2407-10-295.

10.

The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.

Krupski T, Harding MA, Herce ME, Gulding KM, Stoler MH, Theodorescu D.

Growth Factors. 2001;18(4):287-302.

PMID:
11519827
11.

Perforin is a major contributor to NK cell control of tumor metastasis.

Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA.

J Immunol. 1999 Jun 1;162(11):6658-62.

12.

SCID-hu mice for the study of human cancer metastasis.

Namikawa R, Shtivelman E.

Cancer Chemother Pharmacol. 1999;43 Suppl:S37-41.

PMID:
10357557
13.

NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.

Grundy MA, Zhang T, Sentman CL.

Cancer Immunol Immunother. 2007 Aug;56(8):1153-61. Epub 2006 Dec 8.

PMID:
17160409
14.

A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.

Tsingotjidou AS, Ahluwalia R, Zhang X, Conrad H, Emmanouilides C.

Int J Oncol. 2003 Dec;23(6):1569-74.

PMID:
14612928
15.
16.

Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).

Yamamichi F, Matsuoka T, Shigemura K, Kawabata M, Shirakawa T, Fujisawa M.

Urology. 2012 Oct;80(4):951.e1-7. doi: 10.1016/j.urology.2012.06.023. Epub 2012 Aug 22.

PMID:
22920407
17.
18.

Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.

Wang ZX, Lu BB, Yang JS, Wang KM, De W.

J Surg Res. 2011 Nov;171(1):127-35. doi: 10.1016/j.jss.2009.12.016. Epub 2010 Jan 14.

PMID:
20338593
19.

Novel metastasis model of human lung cancer in SCID mice depleted of NK cells.

Yano S, Nishioka Y, Izumi K, Tsuruo T, Tanaka T, Miyasaka M, Sone S.

Int J Cancer. 1996 Jul 17;67(2):211-7.

PMID:
8760590
20.

MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.

Zhang F, Wang Y, Xu M, Dong H, Liu N, Zhou J, Pang H, Ma N, Zhang N, Pei Y, Zhang H, Liu L.

Oncol Rep. 2013 Jun;29(6):2283-90. doi: 10.3892/or.2013.2396. Epub 2013 Apr 9.

PMID:
23588894
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk